Press release
Why Is the Digestion Probiotic Supplement Market Becoming a Key Investment Opportunity Amid Rising Gut Microbiome Awareness and Growing Demand for Targeted Digestive Health Solutions?
As consumers increasingly connect digestive health with immunity, metabolic wellness and preventive nutrition, the digestion probiotic supplement industry is moving beyond conventional daily gut-health products. Manufacturers are focusing on clinically researched probiotic strains, multi-ingredient formulations and convenient delivery formats to address specific digestive concerns. This is shifting competition toward products that offer stronger scientific validation, improved bacterial stability and targeted digestive support.DataM Intelligence estimates the global digestion probiotic supplement market reached US$ 10.46 billion in 2025 and is expected to reach US$ 17.34 billion by 2035, growing with a CAGR of 6.5% during the forecast period 2026-2035. North America is identified as the fastest-growing region in the report, supported by consumer awareness of gut health, established supplement distribution networks and demand for premium probiotic formulations.
Request Executive Sample:
https://www.datamintelligence.com/download-sample/digestion-probiotic-supplement-market?sindhuri
Recent product launches and microbiome research collaborations show how companies are moving toward strain-specific formulations and clinically supported digestive health solutions. For supplement manufacturers, the competitive opportunity is no longer limited to increasing probiotic content. It is increasingly about selecting effective strains, maintaining bacterial viability, improving delivery through the gastrointestinal tract and developing products that meet specific consumer requirements.
Recent Developments
October 26, 2026 - IFF introduced HOWARU® GutABAliteTM, a GABA-producing probiotic strain, Levilactobacillus brevis LBR-6108TM, developed for metabolic health applications. A randomized, double-blind, placebo-controlled human study associated supplementation with lower daily glucose exposure and favorable changes in insulin-related measures. The launch expands the commercial positioning of probiotics beyond conventional digestive support toward interconnected gut and metabolic health.
September 9, 2026 - BioGaia announced the launch of BioGaia® Colus®, a clinically researched probiotic formulation designed to support colon health. The product contains the proprietary L. reuteri BG-R59® strain and uses delayed-release capsule technology to deliver probiotics further into the gastrointestinal tract. The formulation is FODMAP-friendly, with the UK selected as its initial launch market.
June 25, 2026 - Vibrant Nutraceuticals launched Stomach Pro+®, a postbiotic digestive health supplement featuring the patented LJ88® strain (Lactobacillus johnsonii #1088) and Morinaga BB536. The stick-pack formulation focuses on stomach acid balance and gut microbiome support, highlighting growing interest in stable postbiotic alternatives to conventional live probiotic products.
May 7, 2026 - BioGaia launched BioGaia® Protectis® Plus, a next-generation dual-strain probiotic baby supplement. The formulation combines L. reuteri Protectis® with the patented L. reuteri BG-R46® strain and targets digestive discomfort in infants, including colic and unsettled stomachs. The launch strengthens the pediatric digestive health segment through strain combination and product innovation.
March 12, 2026 - Opella and Verb Biotics announced a strategic exclusive partnership to develop and commercialize a next-generation probiotic strain. The collaboration combines Opella's global commercialization capabilities with Verb Biotics' microbiome research expertise, targeting digestive wellness and interconnected health applications. The agreement highlights the growing importance of specialized biotechnology partnerships in probiotic ingredient development.
Purchase This Exclusive Report:
https://www.datamintelligence.com/buy-now-page?report=digestion-probiotic-supplement-market?sindhuri
Key Mergers and Acquisitions
✅ Eris Lifesciences acquired the branded prescription probiotics business of Velbiom Probiotics Private Limited for INR 50 crore on March 20, 2026, through a business transfer agreement executed on the same date, with the transaction completed on March 31, 2026. The acquisition included three probiotic brands: Lactogut, a multi-strain gastrointestinal health formulation; Lactogut UG, a women's urogenital wellness product; and Lactovit, a gut wellness and immune-support supplement. The transaction strengthens Eris Lifesciences' metabolic wellness and women's healthcare portfolios while expanding its presence in India's microbiome-based therapeutics market.
✅ Metagenics acquired UK-based probiotic brand Symprove from bd-capital on January 22, 2026, expanding its science-backed digestive health and nutritional supplement portfolio. Symprove is known for its clinically researched, water-based probiotic formulation designed to support gut microbiome health and digestive wellness. The acquisition allows Metagenics to leverage its international healthcare practitioner network to expand Symprove's market reach. Alongside the transaction, Metagenics and its sponsor, Gryphon Investors, completed a strategic debt recapitalization to support further organic growth and acquisitions. The financial terms of the acquisition were not disclosed.
✅ Danone acquired Belgium-based The Akkermansia Company (TAC) on June 25, 2025, strengthening its investment in gut health and next-generation biotic research. The acquisition brought TAC's proprietary Akkermansia muciniphila MucTTM strain and nearly two decades of microbiome research into Danone's portfolio. The strain has been clinically investigated for its potential to reinforce the gut barrier, reduce inflammation and support metabolic health. The transaction supports Danone's Renew strategy and expands its capabilities in science-led nutrition and microbiome-based health solutions.
✅ Symrise completed its acquisition of the remaining outstanding shares of Swedish probiotic company Probi AB during the first half of 2025, making Probi a wholly owned subsidiary. Symrise had previously held approximately 69.7% of Probi and initiated a cash offer to minority shareholders in November 2024, offering SEK 350 per share. The acquisition strengthened Symrise's position in science-based probiotic and biotic ingredients for nutritional supplements, functional foods and other health-focused applications. It also enabled closer integration of Probi's research, bacterial culture manufacturing and product development capabilities with Symrise's global health and nutrition business.
The Strategic Value of Two Market Segments
General digestive health represents the broader consumer opportunity, supported by routine supplement consumption and increasing interest in maintaining gut microbiome balance. Products targeting everyday digestive wellness can attract repeat purchases through capsules, powders, sachets and other convenient formats. Manufacturers are increasingly differentiating these products through clinically studied strains, multi-strain combinations and formulations designed to support digestive regularity and gastrointestinal comfort. The opportunity is moving toward products that combine scientific validation with convenient daily use, helping brands strengthen consumer trust and recurring demand.
Targeted digestive issues, particularly IBS management, represent a more specialized product opportunity. Consumers seeking support for bloating, abdominal discomfort and irregular bowel movements are creating demand for formulations with specific probiotic strains and clearly defined functional positioning. This segment places greater importance on clinical evidence, strain identification, product stability and appropriate health claims. Ingredient suppliers and supplement manufacturers that can demonstrate research-backed benefits and develop targeted formulations have opportunities to compete in higher-value digestive wellness categories. ADM's Esflorin1TM portfolio, for example, includes probiotic and postbiotic solutions positioned around digestive health and IBS symptom support.
Regional Opportunities
United States: The market benefits from an established nutritional supplements industry, strong consumer awareness of gut microbiome health and extensive availability of probiotic products through pharmacies, specialty retailers and e-commerce platforms. Demand is expanding beyond conventional digestive support toward clinically studied strains, microbiome-focused formulations and combination products. Manufacturers can differentiate through strain-specific research, transparent labeling, convenient dosage formats and subscription-based distribution. Regulatory compliance and substantiation of digestive health claims remain important considerations for commercial expansion.
Japan: Japan represents an established probiotic market supported by longstanding consumer familiarity with beneficial bacteria, functional foods and digestive wellness products. Companies are extending probiotic innovation through functional-claim products and formulations addressing multiple wellness needs. Yakult's June 2026 introduction of Yakult 400 Immunity and Gut Health and Yakult 400LT Immunity and Gut Health illustrates the development of products combining intestinal environment and immune-function positioning. Such developments create opportunities for manufacturers offering differentiated probiotic strains, clinically supported formulations and products adapted to local consumer preferences.
Company Profiles
- BioGaia AB: The company focuses on clinically researched probiotic strains, particularly Lactobacillus reuteri-based formulations. On September 9, 2026, BioGaia announced BioGaia Colus, a probiotic product containing its proprietary L. reuteri BG-R59 strain, developed for colon health. Its delayed-release capsule technology is designed to deliver probiotics farther into the gastrointestinal tract, initially targeting the UK market before expansion into selected international markets.
- Danone S.A.: Danone participates in the digestive wellness category through its Activia portfolio and expertise in fermentation and probiotic cultures. In 2025, the company expanded Activia Kefir and introduced Activia Bio Shot in Japan, featuring bifidobacteria selected for their ability to survive stomach acidity. These developments demonstrate its strategy of combining probiotic research with convenient consumer-facing digestive wellness products.
- Yakult Honsha Co., Ltd.: Yakult has an established position in probiotic products built around its proprietary Lacticaseibacillus paracasei strain Shirota. Its June 2026 introduction of Yakult 400 Immunity and Gut Health and Yakult 400LT Immunity and Gut Health demonstrates continued product development around intestinal health and functional food positioning. The company's established distribution network and strain-specific research support its competitive position in Japan and international markets.
- Archer Daniels Midland (ADM): ADM supplies probiotic and postbiotic ingredients for nutritional supplements, functional foods and beverages. Its portfolio includes DE111, BPL1 and Esflorin1, addressing digestive health, microbiome support and other wellness applications. The company's February 2025 exclusive distribution agreement with Asahi Group Foods for the L. gasseri CP2305 postbiotic expanded its ingredient portfolio and strengthened its access to science-backed microbiome applications.
Outlook
The digestion probiotic supplement market will increasingly depend on the ability of manufacturers to translate microbiome research into differentiated, commercially viable products. Demand is shifting from general digestive wellness toward targeted formulations addressing specific gastrointestinal concerns, including IBS management. Recent product introductions from BioGaia, Danone and Yakult highlight the importance of strain-specific innovation, functional positioning and advanced delivery technologies. Companies that combine clinical research, product stability, regulatory compliance and accessible distribution will be better positioned to capture opportunities across established and emerging probiotic markets.
Get 20% complimentary customization within the report:
https://www.datamintelligence.com/customize/digestion-probiotic-supplement-market?sindhuri
Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
About Us :
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why Is the Digestion Probiotic Supplement Market Becoming a Key Investment Opportunity Amid Rising Gut Microbiome Awareness and Growing Demand for Targeted Digestive Health Solutions? here
News-ID: 4690608 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Why Is the Lithium Niobate Market Emerging as a Key Investment Opportunity Amid …
The global photonics and semiconductor industries are entering a new phase of investment as artificial intelligence (AI) infrastructure, high-speed optical communication and advanced computing increase demand for materials capable of handling faster data transmission and more efficient signal processing. Lithium niobate is gaining strategic importance because of its strong electro-optic, nonlinear optical and piezoelectric properties. Its thin-film form, particularly thin-film lithium niobate (TFLN), is creating new opportunities in photonic integrated…
Why Is the Oil and Gas EPC Market Becoming a Key Investment Opportunity Amid Ris …
The global oil and gas industry is entering a new infrastructure investment cycle as energy security concerns, rising fuel consumption and increasing demand for natural gas drive investments across upstream, midstream and downstream operations. Engineering, Procurement and Construction (EPC) services are becoming increasingly important as energy companies undertake large-scale offshore developments, LNG infrastructure expansion, pipeline construction and refinery modernization projects. This is shifting EPC demand toward integrated project execution, where…
Why Is the Flexible Packaging Market Becoming a Key Investment Opportunity Amid …
The global packaging industry is undergoing a major transformation as consumer goods manufacturers, food producers and retailers seek packaging formats that combine product protection, convenience and environmental responsibility. Flexible packaging is becoming increasingly important in this transition, particularly as companies move toward lightweight pouches, resealable bags, high-barrier films and recyclable packaging structures. The shift toward mono-material solutions, improved barrier technologies and paper-based alternatives is changing how manufacturers approach packaging design,…
Why Is the Recycled PET Market Becoming a Key Investment Opportunity Amid Rising …
The global plastics and packaging industry is undergoing a major shift as governments introduce recycled-content requirements, beverage companies strengthen packaging sustainability commitments and manufacturers seek alternatives to virgin plastic. Recycled polyethylene terephthalate (rPET) is becoming an important material in this transition, particularly across food and beverage bottles, packaging containers, films, sheets and textile applications. The industry is also moving beyond conventional bottle-to-fiber recycling toward high-quality bottle-to-bottle recycling, food-grade recycled resin…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
